Abecma (Idecabtagene vicleucel)

Overview
Abecma is a therapy approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory multiple myeloma after four or more prior therapies, including an immunomodulatory agent,… read more

Adriamycin (Doxorubicin)

The Adriamycin brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to… read more

Alkeran (Melphalan)

The Alkeran brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your…

Aredia (Pamidronate)

Overview
Aredia is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat and prevent osteolytic (bone) lesions caused by multiple myeloma. Some doctors may also prescribe Aredia for people… read more

Autologous (self) stem cell transplant

Overview
Stem cell transplant after high-dose chemotherapy is the most common treatment for people when first diagnosed with multiple myeloma. The purpose of a stem cell transplant in multiple myeloma is to replace… read more

BiCNU (Carmustine)

Overview
BiCNU is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating multiple myeloma and other cancers. BiCNU is often combined with other drugs such as corticosteroids.… read more

Blenrep (Belantamab Mafodotin-Blmf) for Multiple Myeloma

Blenrep (belantamab mafodotin-blmf) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with relapsed or refractory…

Boruzu (Bortezomib)

Overview
Boruzu is approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma. It may be used as an initial treatment or as part of retreatment if the disease returns. Eligibility…

Carvykti (Ciltacabtagene Autoleucel) for Multiple Myeloma

Carvykti (ciltacabtagene autoleucel) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Cytoxan (Cyclophosphamide)

The Cytoxan brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more

Darzalex (Daratumumab) for Multiple Myeloma

Darzalex (daratumumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Darzalex Faspro (Daratumumab and Hyaluronidase-Fihj) for Multiple Myeloma

Darzalex Faspro (daratumumab and hyaluronidase-fihj) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with multiple…

Doxil (Doxorubicin liposomal)

Overview

Doxil is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating cancers including multiple myeloma. In cases of myeloma, Doxil is usually combined with Velcade and…

Elrexfio (Elranatamab-Bcmm) for Multiple Myeloma

Elrexfio (elranatamab-bcmm) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Empliciti (Elotuzumab) for Multiple Myeloma

Empliciti (elotuzumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma in combination…

Evomela (Melphalan)

Overview
Evomela is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating multiple myeloma. Evomela is often combined with other drugs such as Velcade or Thalomid and a corticost… read more

Farydak (Panobinostat)

The Farydak brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more

Kyprolis (Carfilzomib)

Kyprolis (carfilzomib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory multiple myeloma…

Lynozyfic (Linvoseltamab-Gcpt) for Multiple Myeloma

Lynozyfic (linvoseltamab-gcpt) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory multiple myeloma.

Mozobil (Plerixafor)

Overview
Mozobil is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat multiple myeloma and non-Hodgkin lymphoma. Mozobil is also known by its drug name, plerixafor.

Mozobil is a… read more